Felipe Duran Buys 9,191 Shares of iBio, Inc. (NYSE:IBIO) Stock

iBio, Inc. (NYSE:IBIO) CFO Felipe Duran acquired 9,191 shares of iBio stock in a transaction that occurred on Friday, January 10th. The shares were bought at an average cost of $2.72 per share, with a total value of $24,999.52. Following the transaction, the chief financial officer now owns 11,139 shares in the company, valued at $30,298.08. This represents a 471.82 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this link.

iBio Trading Down 2.7 %

iBio stock traded down $0.07 during mid-day trading on Monday, hitting $2.48. The company had a trading volume of 259,145 shares, compared to its average volume of 162,895. iBio, Inc. has a 12 month low of $1.02 and a 12 month high of $4.98. The stock’s 50 day moving average price is $2.51 and its two-hundred day moving average price is $2.29. The company has a current ratio of 3.37, a quick ratio of 3.37 and a debt-to-equity ratio of 0.04.

iBio (NYSE:IBIO) last announced its quarterly earnings results on Tuesday, November 12th. The company reported ($0.46) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.46). Research analysts expect that iBio, Inc. will post -1.74 EPS for the current fiscal year.

iBio Company Profile

iBio, Inc, a biotechnology company, engages in the development of precision antibodies in the United States. It offers IBIO-100, a preclinical anti-fibrotic program for the treatment of systemic scleroderma and idiopathic pulmonary fibrosis; and EngageTx platform, which provides an optimized CD3 T-cell engager antibody panel.